OJR 9188
Alternative Names: OJ-R9188Latest Information Update: 26 Mar 2008
At a glance
- Originator Nippon Organon
- Class Guanidines; Skin disorder therapies
- Mechanism of Action Selectin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atopic dermatitis; Reperfusion injury
Most Recent Events
- 05 Jun 2002 Preclinical trials in Atopic dermatitis in Japan (unspecified route)
- 05 Jun 2002 Preclinical trials in Reperfusion injury in Japan (unspecified route)